Journal of Investigative Medicine High Impact Case Reports (Apr 2022)

Successful Laparoscopic Treatment of Pancreatic Metastasis From Sigmoid Colon Cancer: A Case Report

  • Masatsugu Ishii MD, PhD,
  • Yoshihiro Inoue MD, PhD,
  • Kentaro Matsuo MD, PhD,
  • Yuta Miyaoka MD, PhD,
  • Hiroki Hamamoto MD, PhD,
  • Wataru Osumi MD, PhD,
  • Shinsuke Masubuchi MD, PhD,
  • Masashi Yamamoto MD, PhD,
  • Toshikatsu Nitta MD, PhD,
  • Takashi Ishibashi MD, PhD,
  • Keitaro Tanaka MD, PhD,
  • Junji Okuda MD,PhD,
  • Kazuhisa Uchiyama MD,PhD

DOI
https://doi.org/10.1177/23247096221074586
Journal volume & issue
Vol. 10

Abstract

Read online

Progressive colorectal cancer frequently presents with various manifestations, including hepatic, pulmonary, and peritoneal metastases, as well as local and anastomotic site recurrences. However, pancreatic metastasis is extremely rare. Complete surgical resection is currently considered the most effective and only potentially curative treatment for colorectal cancer with distant metastases. We report the successful laparoscopic treatment of a patient with pancreatic metastasis after initial surgery for Stage IV sigmoid colon cancer with pulmonary metastasis. An 84-year-old man was initially diagnosed with sigmoid colon cancer and pulmonary metastasis. Laparoscopic sigmoidectomy and thoracoscopic partial resection of the right lung were performed in 2017. After 8 months, an approximately 20-mm tumor was detected in the pancreatic tail during imaging investigations. We performed laparoscopic distal pancreatectomy without lymph node dissection at 1 year after the initial operation. The histopathological findings suggested metachronous pancreatic metastasis from the sigmoid colon cancer. The patient has had an uneventful postoperative course with no signs of recurrent disease during 29 months of follow-up after the pancreatic surgery. After prior surgery for Stage IV sigmoid colon cancer with pulmonary metastasis, curative resection was performed for pancreatic metastasis. We believe that curative resection may be useful for pancreatic tumors that involve hematogenous metastasis.